Intelligent Bio Solutions (INBS) Total Debt (2020 - 2024)
Intelligent Bio Solutions has reported Total Debt over the past 5 years, most recently at $150426.0 for Q1 2024.
- Quarterly results put Total Debt at $150426.0 for Q1 2024, down 68.05% from a year ago — trailing twelve months through Mar 2024 was $150426.0 (down 68.05% YoY), and the annual figure for FY2023 was $402862.0, down 85.8%.
- Total Debt for Q1 2024 was $150426.0 at Intelligent Bio Solutions, down from $230969.0 in the prior quarter.
- Over the last five years, Total Debt for INBS hit a ceiling of $5.1 million in Q2 2020 and a floor of $9536.0 in Q4 2021.
- Median Total Debt over the past 5 years was $354548.0 (2023), compared with a mean of $829892.5.
- Biggest five-year swings in Total Debt: crashed 99.74% in 2021 and later skyrocketed 21190.87% in 2022.
- Intelligent Bio Solutions' Total Debt stood at $431621.0 in 2020, then tumbled by 97.79% to $9536.0 in 2021, then skyrocketed by 5220.92% to $507403.0 in 2022, then crashed by 54.48% to $230969.0 in 2023, then tumbled by 34.87% to $150426.0 in 2024.
- The last three reported values for Total Debt were $150426.0 (Q1 2024), $230969.0 (Q4 2023), and $306234.0 (Q3 2023) per Business Quant data.